fb-pixel Skip to main content

More business headlines

Cambridge biotech wins approval for much-debated ALS drug

The closely watched drug, called Relyvrio, was developed by Cambridge-based Amylyx Pharmaceuticals.

Russia to annex more of Ukraine on Friday at the Kremlin

Russia planned to annex more of Ukraine on Friday in an escalation of the seven-month war that was expected to isolate the Kremlin further, draw more international punishment, and bring Ukraine extra military, political, and economic support.

Fewer people seek US unemployment aid amid solid hiring

The number of Americans filing for jobless benefits dropped last week, a sign that few companies are cutting jobs despite high inflation and a weak economy.

US economy weaker than thought in year’s first half, by one measure

Gross domestic income, adjusted for inflation, grew at a 0.8 percent annual rate in the first quarter of the year and barely grew at all — at just a 0.1 percent rate — in the second, the Commerce Department said Thursday. That was sharply weaker than the 1.8 percent and 1.4 percent growth rates reported in earlier estimates.

More shippers on board after $850m expansion of Boston freight terminal

Massport says dredging and expansion projects are paying off.

Wall Street drops back to lowest since 2020 as fear returns

Stocks fell broadly on Wall Street Thursday as worries about a possible recession and rising bond yields put the squeeze back on markets.

Ian’s aftermath even harder to fix with supply chain in tatters

The storm is expected to cause some $60 billion to $100 billion in damage, and construction groups warn that labor shortages and supply-chain difficulties may hamper rebuilding efforts.

House approves scaled-down bill targeting Big Tech dominance

The bipartisan measure, passed by a 242-184 vote, pales in comparison with a more ambitious package aimed at reining in Meta, Google, Amazon and Apple and cleared by key House and Senate committees.